Expertise in
5
conditions

Nicholas O. Opoku

Accra, AA, GH 
Expertise in
5
conditions
Accra, AA, GH 

Overview

Nicholas Opoku practices practicing medicine in Accra, Ghana.

Opoku is highly rated in 5 conditions, according to our data. Their clinical expertise encompasses Onchocerciasis, Childhood Volvulus, Spirurida Infections, and Secernentea Infections.

They are actively involved in clinical research, co-authoring 31 peer reviewed articles and participating in 3 clinical trials.

Locations

Accra, AA, Ghana
Other Locations
University of Cape Coast
Cape Coast, CP, Ghana
Kumasi, AH, Ghana
Ho, TV, Ghana

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

An Open-label Study of the Pharmacokinetics and Safety of a Single Dose of Moxidectin Per Oral in Subjects Aged 4 to 17 Years With (or at Risk of) Onchocerciasis to Identify an Optimal Dose for Treatment of Children 4 to 11 Years
An Open-label Study of the Pharmacokinetics and Safety of a Single Dose of Moxidectin Per Oral in Subjects Aged 4 to 17 Years With (or at Risk of) Onchocerciasis to Identify an Optimal Dose for Treatment of Children 4 to 11 Years
Enrollment Status: Completed
Publish Date: September 05, 2025
Intervention Type: Drug
Study Drug: Moxidectin
Study Phase: Phase 1
A Phase-II, Randomised, Double-blind, Parallel-group Trial to Investigate Emodepside (BAY 44-4400) in Subjects With Onchocerca Volvulus Infection, Comprising: Part 1 to Investigate Safety, Tolerability, Pharmacodynamics, Pharmacokinetics and Dose-Response Relationship for Efficacy (Proof-of-Concept); Part 2 to Investigate Efficacy of Selected Doses, Safety, Tolerability and Pharmacokinetics
A Phase-II, Randomised, Double-blind, Parallel-group Trial to Investigate Emodepside (BAY 44-4400) in Subjects With Onchocerca Volvulus Infection, Comprising: Part 1 to Investigate Safety, Tolerability, Pharmacodynamics, Pharmacokinetics and Dose-Response Relationship for Efficacy (Proof-of-Concept); Part 2 to Investigate Efficacy of Selected Doses, Safety, Tolerability and Pharmacokinetics
Enrollment Status: Active_not_recruiting
Publish Date: March 05, 2024
Intervention Type: Drug
Study Drugs: Emodepside, Ivermectin
Study Phase: Phase 2
Comparison of Ivermectin Alone With Albendazole (ALB) Plus Ivermectin (IVM) in Their Efficacy Against Onchocerciasis in the Volta Region, Ghana.
Comparison of Ivermectin Alone With Albendazole (ALB) Plus Ivermectin (IVM) in Their Efficacy Against Onchocerciasis in the Volta Region, Ghana.
Enrollment Status: Completed
Publish Date: April 26, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

31 Total Publications

Optimal control of Typhoid fever transmission under environmental and public health interventions.
Optimal control of Typhoid fever transmission under environmental and public health interventions.
Journal: PloS one
Published: February 20, 2026

Frequently Asked Questions about Nicholas O. Opoku

Is Nicholas O. Opoku a top-rated expert for Onchocerciasis?

MediFind is an objective health platform that identifies experts based on real-world data. Nicholas O. Opoku is classified as an Elite expert for Onchocerciasis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Nicholas O. Opoku participate in research or clinical trials?

Yes. Nicholas O. Opoku has published 31 articles and abstracts on conditions like Onchocerciasis. You can view a list of Nicholas O. Opoku's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Opoku's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile